Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype

Clinical and Experimental Immunology

Volumn 183, Issue 1, 2016, Pages 150-156

  Lachmann, P J ^a   Lay, E ^a   Seilly, D J ^a   Buchberger, A ^a   Schwaeble, W ^b   Khadake, J ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

C3b feedback cycle; CR1; Factor I; Serum complotypes

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT FACTOR H; ENDOTOXIN; FIBRINOGEN; LIPOPOLYSACCHARIDE; PROTEIN; PROTEIN C3DG; PROTEIN IC3B; UNCLASSIFIED DRUG; ANTISERUM; COMPLEMENT FACTOR I; CR1 PROTEIN, HUMAN; ECULIZUMAB; MONOCLONAL ANTIBODY;

AGE DISTRIBUTION; ALLELE; ALLOTYPE; AREA UNDER THE CURVE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; ERYTHROCYTE; FEEDBACK SYSTEM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM; ADOLESCENT; ADULT; AGE; AGED; BLOOD; DOWN REGULATION; GENETICS; HEMOGLOBINURIA, PAROXYSMAL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; COMPLEMENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; DOWN-REGULATION; ERYTHROCYTES; GENE FREQUENCY; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNE SERA; LIPOPOLYSACCHARIDES; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3B; YOUNG ADULT;

EID: 84955344981     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12714     Document Type: Article

References (8)

1. Lay E, Nutland S, Smith JE et al. Complotype affects the extent of down-regulation by Factor I of the C3b feedback cycle in vitro. Clin Exp Immunol 2014; 181:314-22.
2. Smith RA. Targeting anticomplement agents. Biochem Soc Trans 2002; 30:1037-41.
3. Rondelli T, Risitano AM, Peffault de Latour R et al. Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. Haematologica 2014; 99:262-6.
4. Mollison PL, Englefriet CP, Contreras M. Chapter 7; Blood transfusion in clinical medicine, 9th edn. Oxford, UK: Blackwell Scientific Publications, 1993:288.
5. Hogg N, Ross GD, Jones DB, Slusarenko M, Walport MJ, Lachmann PJ. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol 1984; 14:236-43.
6. http://www.statisticshowto.com/how-to-find-the-area-under-curve-in-microsoft-excel/.
7. Kavanagh D, Yu Y, Schramm EC, Triebwasser M, et al. Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum Mol Genet 2015; 24:3861-70.
8. Sorensen H, Dissing J. C3 polymorphism in relation to age. Hum Hered 1975; 25:284-95.